| ChEBI: a database and ontology for chemical entities of biological interest K Degtyarenko, P De Matos, M Ennis, J Hastings, M Zbinden, A McNaught, ... Nucleic acids research 36 (suppl 1), D344-D350, 2008 | 1447* | 2008 |
| A comprehensive evaluation of normalization methods for Illumina high-throughput RNA sequencing data analysis MA Dillies, A Rau, J Aubert, C Hennequet-Antier, M Jeanmougin, ... Briefings in bioinformatics 14 (6), 671-683, 2013 | 1428 | 2013 |
| Analysis of drug combinations: current methodological landscape J Foucquier, M Guedj Pharmacology research & perspectives 3 (3), e00149, 2015 | 788 | 2015 |
| A refined molecular taxonomy of breast cancer M Guedj, L Marisa, A de Reynies, B Orsetti, R Schiappa, F Bibeau, ... Oncogene, 2011 | 298 | 2011 |
| A comparison of six methods for missing data imputation P Schmitt, J Mandel, M Guedj Journal of Biometrics & Biostatistics 6 (1), 1, 2015 | 222 | 2015 |
| Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: A new perspective for pulmonary fibrosis P Dieudé, M Guedj, J Wipff, J Avouac, I Fajardy, E Diot, B Granel, J Sibilia, ... Arthritis & Rheumatism 60 (1), 225-233, 2009 | 209 | 2009 |
| Should we abandon the t-test in the analysis of gene expression microarray data: a comparison of variance modeling strategies M Jeanmougin, A De Reynies, L Marisa, C Paccard, G Nuel, M Guedj PloS one 5 (9), e12336, 2010 | 188 | 2010 |
| STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis P Dieudé, M Guedj, J Wipff, B Ruiz, E Hachulla, E Diot, B Granel, J Sibilia, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 168 | 2009 |
| Comparative functional genomics revealed conservation and diversification of three enhancers of the isl1 gene for motor and sensory neuron-specific expression O Uemura, Y Okada, H Ando, M Guedj, S Higashijima, T Shimazaki, ... Developmental biology 278 (2), 587-606, 2005 | 161 | 2005 |
| An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth … S Attarian, JM Vallat, L Magy, B Funalot, PM Gonnaud, A Lacour, ... Orphanet journal of rare diseases 9 (1), 1-15, 2014 | 135* | 2014 |
| Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population P Dieude, M Guedj, J Wipff, B Ruiz, G Riemekasten, M Matucci-Cerinic, ... Annals of the rheumatic diseases 69 (11), 1958-1964, 2010 | 134 | 2010 |
| BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4 P Dieudé, J Wipff, M Guedj, B Ruiz, I Melchers, E Hachulla, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2009 | 123 | 2009 |
| The PTPN22 620W allele confers susceptibility to systemic sclerosis: Findings of a large case–control study of European Caucasians and a meta‐analysis P Dieudé, M Guedj, J Wipff, J Avouac, E Hachulla, E Diot, B Granel, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2008 | 113 | 2008 |
| NLRP1 influences the systemic sclerosis phenotype: a new clue for the contribution of innate immunity in systemic sclerosis-related fibrosing alveolitis pathogenesis P Dieude, M Guedj, J Wipff, B Ruiz, G Riemekasten, P Airo, I Melchers, ... Annals of the rheumatic diseases 70 (4), 668-674, 2011 | 87 | 2011 |
| Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of … I Chumakov, A Milet, N Cholet, G Primas, A Boucard, Y Pereira, ... Orphanet Journal of Rare Diseases 9, 201, 2014 | 85 | 2014 |
| Variants of the MATP/SLC45A2 gene are protective for melanoma in the French population M Guedj, A Bourillon, C Combadières, M Rodero, P Dieudé, V Descamps, ... Human mutation 29 (9), 1154-1160, 2008 | 77 | 2008 |
| Phenotype-haplotype correlation of IRF5 in systemic sclerosis: role of 2 haplotypes in disease severity P Dieude, K Dawidowicz, M Guedj, Y Legrain, J Wipff, E Hachulla, E Diot, ... The Journal of rheumatology 37 (5), 987-992, 2010 | 73 | 2010 |
| Clinically relevant characterization of lung adenocarcinoma subtypes based on cellular pathways: an international validation study CM Bryant, DL Albertus, S Kim, G Chen, C Brambilla, M Guedj, C Arima, ... PloS one 5 (7), e11712, 2010 | 68 | 2010 |
| Accounting for population stratification in practice: a comparison of the main strategies dedicated to genome-wide association studies M Bouaziz, C Ambroise, M Guedj PloS one 6 (12), e28845, 2011 | 67 | 2011 |
| Association of the CD226 Ser307 variant with systemic sclerosis: Evidence of a contribution of costimulation pathways in systemic sclerosis pathogenesis P Dieudé, M Guedj, ME Truchetet, J Wipff, L Revillod, G Riemekasten, ... Arthritis & Rheumatism 63 (4), 1097-1105, 2011 | 67 | 2011 |
Marine JeanmouginInstitute for Cancer Research, Radium HospitalBestätigte E-Mail-Adresse bei rr-research.no
